Abstract

There is a gap in knowledge regarding the polygenic underpinnings of brain anomalies observed in youth bipolar disorder (BD). This study examined the association of a polygenic risk score for BD (BD-PRS) with grey matter structure and white matter integrity in youth with and without BD. 113 participants were included in the analyses, including 78 participants with both T1-weighted and diffusion-weighted MRI images, 32 participants with T1-weighted images only, and 3 participants with diffusion-weighted images only. BD-PRS was calculated using PRS-CS-auto and was based on independent adult genome-wide summary statistics. Vertex- and voxel-wise analyses examined the associations of BD-PRS with grey matter metrics (cortical volume [CV], cortical surface area [CSA], cortical thickness [CTh]) and fractional anisotropy [FA] in the combined sample, and separately in BD and HC. In the combined sample of participants with T1-weighted images (n = 110, 66 BD, 44 HC), higher BD-PRS was associated with smaller grey matter metrics in frontal and temporal regions. In within-group analyses, higher BD-PRS was associated with lower CTh of frontal, temporal, and fusiform gyrus in BD, and with lower CV and CSA of superior frontal gyrus in HC. In the combined sample of participants with diffusion-weighted images (n = 81, 49 BD, 32 HC), higher BD-PRS was associated with lower FA in widespread white matter regions. In summary, BD-PRS calculated based on adult genetic data was negatively associated with grey matter structure and FA in youth in regions implicated in BD, which may suggest neuroimaging markers of vulnerability to BD. Future longitudinal studies are needed to examine whether BD-PRS predicts neurodevelopmental changes in BD vs. HC and its interaction with course of illness and long-term medication use.

Details

Title
Association of polygenic risk for bipolar disorder with grey matter structure and white matter integrity in youth
Author
Jiang, Xinyue 1   VIAFID ORCID Logo  ; Zai, Clement C. 2   VIAFID ORCID Logo  ; Kennedy, Kody G. 3   VIAFID ORCID Logo  ; Zou, Yi 3   VIAFID ORCID Logo  ; Nikolova, Yuliya S. 2   VIAFID ORCID Logo  ; Felsky, Daniel 4   VIAFID ORCID Logo  ; Young, L. Trevor 5 ; MacIntosh, Bradley J. 6 ; Goldstein, Benjamin I. 7   VIAFID ORCID Logo 

 Centre for Addiction and Mental Health, Centre for Youth Bipolar Disorder, Toronto, Canada (GRID:grid.155956.b) (ISNI:0000 0000 8793 5925); University of Toronto, Department of Pharmacology & Toxicology, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
 Centre for Addiction and Mental Health, Toronto, Canada (GRID:grid.155956.b) (ISNI:0000 0000 8793 5925); University of Toronto, Department of Psychiatry, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
 Centre for Addiction and Mental Health, Centre for Youth Bipolar Disorder, Toronto, Canada (GRID:grid.155956.b) (ISNI:0000 0000 8793 5925) 
 Centre for Addiction and Mental Health, Toronto, Canada (GRID:grid.155956.b) (ISNI:0000 0000 8793 5925); University of Toronto, Division of Biostatistics, Dalla Lana School of Public Health, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
 University of Toronto, Department of Pharmacology & Toxicology, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938); Centre for Addiction and Mental Health, Toronto, Canada (GRID:grid.155956.b) (ISNI:0000 0000 8793 5925); University of Toronto, Department of Psychiatry, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
 Sunnybrook Research Institute, Sandra E Black Centre for Brain Resilience and Recovery, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938); University of Toronto, Department of Medical Biophysics, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938); Sunnybrook Research Institute, Hurvitz Brain Sciences Program, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
 Centre for Addiction and Mental Health, Centre for Youth Bipolar Disorder, Toronto, Canada (GRID:grid.155956.b) (ISNI:0000 0000 8793 5925); University of Toronto, Department of Pharmacology & Toxicology, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938); University of Toronto, Department of Psychiatry, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
Pages
322
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
21583188
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2878558018
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.